* 2019 ÀÌÈÄ Ãë±Þ ¾ÈÇÔ*Gene Bridges GmbH owns the exclusive rights to Red/ET Recombination, a revolutionary DNA engineering technology. Gene Bridges issues licenses for the use of the Red/ET Recombination technology to commercial users. Licensing arrangements for Red/ET Recombination are provided as world-wide, non-exclusive sub-licenses.
6-Month Trial License6-month trial licenses for EUR 3,500 are available for commercial parties wishing to test the technology. Each license is provided with an attractive support package consisting of:
Full License (standard format)Gene Bridges can customize full licenses to include access to any combination of the following applications:
They can be tailored to fit your requirements.
For more information about the licensing of Red/ET Recombination, please contact licenses@genebridges.com |
»ç¿ëÈıâ ÀÛ¼º
|